11 Nov 2025 | 3 Mins Read
Emcure Pharma sees 25% profit jump to ₹243 crore in Q2
Flipitmoney
Pharma company Emcure Pharmaceuticals has reported a 25.1% year-on-year rise in consolidated net profit to ₹243 crore for Q2 FY25. Revenue grew 13.4% to ₹2,269.8 crore, driven by strong growth in domestic and international markets. EBITDA rose 25% to ₹475.4 crore with a 2% improvement in EBITDA margin.